Kisspeptin-10 20mg — Vial Spec, Reconstitution Math & COA

1. Overview of Kisspeptin-10 in Preclinical Research

Kisspeptin-10 is an endogenous decapeptide derived from the cleavage of the precursor KISS1 gene product. As a primary endogenous ligand for the G protein-coupled receptor KISS1R (formerly GPR54), Kisspeptin-10 functions as a crucial upstream regulator within the reproductive endocrine system. In preclinical models, the peptide acts directly upon gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus, driving downstream signaling cascades that govern luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.

When purchasing high-mass configurations such as 20mg vials, investigators frequently aim to conduct continuous dosing schedules in animal models or populate multiple assay plates without batch-to-batch variation. Understanding the structural properties, handling requirements, and precise mathematical reconstitution of a 20mg mass is critical to maintaining experimental integrity and avoiding degradation of active sequences during prolonged testing protocols.

2. Molecular Mechanism and HPG Axis Signaling Pathways

The primary mechanism of Kisspeptin-10 centers on its high-affinity binding to KISS1R on GnRH-secreting neuroendocrine cells. In vitro receptor binding assays demonstrate that the decapeptide sequence (YNWNSFGLRF-NH2) retains the essential C-terminal domain necessary for full receptor activation and downstream intracellular signaling. Upon receptor binding, a Gq/11-coupled pathway activates phospholipase C (PLC), resulting in intracellular calcium mobilization and protein kinase C (PKC) activation.

Preclinical studies suggest that this intracellular signaling cascade stimulates the localized release of GnRH into the hypophyseal portal system. In rodent and non-human primate models, this upstream drive regulates the pulsatile release of pituitary gonadotropins. Because Kisspeptin-10 resides at the apex of the hypothalamic-pituitary-gonadal (HPG) axis, it remains a central tool for exploring pubertal timing, feedback mechanisms of gonadal steroids, and potential neuroendocrine targets in reproductive physiology.

3. PX1 Product Catalog Availability and High-Mass Sourcing

To ensure maximal flexibility for diverse laboratory requirements, investigators should note the specific packaging configurations offered in our catalog. PX1 Research routinely stocks high-purity single-vial units in standard concentrations, such as our standard Kisspeptin-10 10mg configuration. While standard catalog listings feature the 10mg format, high-density 20mg fills are made available for specialized institutional projects, custom filling runs, and bulk allocations.

Laboratories planning extensive in vitro panels or longitudinal animal studies requiring 20mg or larger cumulative masses can request custom batch fills through our wholesale lab account portal. Alternatively, researchers evaluating smaller pilot studies can browse our all research peptides catalog to select standard vial masses. Regardless of fill size, every lot produced in our facilities undergoes identical rigorous analytical testing and purity verification.

4. Reconstitution Mathematics for 20mg Fills

Accurate reconstitution math is vital when working with a 20mg lyophilized mass to ensure precise concentration delivery across experimental replicates. Because 20mg represents a substantial mass of peptide powder, selecting the correct diluent volume—typically Bacteriostatic Water (0.9% benzyl alcohol) for multi-dose animal studies or Sterile Water for Injection (SWFI) for immediate cell culture applications—determines final stock concentration.

To calculate working stock concentration, researchers use the basic equation: Mass (mg) / Volume (mL) = Concentration (mg/mL). For microgram-level calculations, convert milligrams to micrograms (20mg = 20,000 mcg). To minimize manual calculation errors during preparation, researchers can verify target concentrations using our online reconstitution calculator.

The following standardized volumes demonstrate the math for a 20mg Kisspeptin-10 vial:

• 1.0 mL Diluent Volume: Yields a stock concentration of 20.0 mg/mL (20,000 mcg/mL). Every 0.01 mL (10 µL) volume contains 200 mcg of active peptide.

• 2.0 mL Diluent Volume: Yields a stock concentration of 10.0 mg/mL (10,000 mcg/mL). Every 0.01 mL (10 µL) volume contains 100 mcg of active peptide.

• 3.0 mL Diluent Volume: Yields a stock concentration of 6.67 mg/mL (6,670 mcg/mL). Every 0.01 mL (10 µL) volume contains 66.7 mcg of active peptide.

• 4.0 mL Diluent Volume: Yields a stock concentration of 5.0 mg/mL (5,000 mcg/mL). Every 0.01 mL (10 µL) volume contains 50 mcg of active peptide.

5. Aliquot Planning and Workflow Optimization

Once a 20mg Kisspeptin-10 vial is reconstituted, repeatedly freeze-thawing the master stock solution must be avoided. Repeated freeze-thaw cycles cause mechanical shear forces and temperature fluctuations that break down peptide bonds, accelerating sequence degradation and causing inconsistent assay output. Laboratory protocols should dictate immediate division of the reconstituted stock into single-use micro-aliquots using sterile, polypropylene microcentrifuge tubes.

For example, if a laboratory utilizes 2.0 mL of reconstituting diluent to produce a 10 mg/mL stock, the solution should be divided into twenty 100 µL aliquots (each containing 1 mg) or forty 50 µL aliquots (each containing 500 mcg). Aliquots intended for short-term use (within 24 to 48 hours) may be kept at 2°C to 8°C, while long-term stock aliquots must be immediately stored at -20°C or -80°C until experimental deployment.

6. Analytical Purity Verification and Lot-Matched COA

PX1 Research enforces strict quality control standards for every lyophilized lot. Each batch of Kisspeptin-10 undergoes comprehensive analytical verification at an independent, ISO 17025 accredited laboratory prior to release. High-Performance Liquid Chromatography (HPLC) is performed to verify peptide purity levels exceeding 98%, ensuring that truncated sequences or synthesis side-products do not interfere with binding affinity assays.

Additionally, Mass Spectrometry (MS) analysis is conducted to confirm precise identity by measuring the target molecular mass. Crucially, every fill mass—whether packaged as a standard 10mg unit or custom 20mg format—is supported by a lot-matched Certificate of Analysis. Investigators can access and download verified testing documentation directly through our dedicated COA lookup database. Endotoxin levels are also quantified via Chromogenic LAL testing to ensure levels remain well below published threshold guidelines (<0.01 EU/mg), protecting primary cell cultures and animal models from endotoxin-induced immune confounding.

7. Comparative Upstream HPG Axis Research Compounds

When evaluating upstream signaling across the reproductive axis, investigators frequently compare Kisspeptin-10 against other neuropeptides and receptor agonists targeting different levels of the hypothalamic-pituitary cascade. Selecting the appropriate research compound depends entirely on whether the experimental focus centers on direct hypothalamic stimulation, pituitary receptor desensitization, or downstream gonadal response.

For instance, while Kisspeptin-10 acts as an upstream trigger directly at the hypothalamic GnRH neuron level, downstream pituitary receptors are routinely investigated using compounds such as Triptorelin, a potent GnRH receptor agonist that induces initial gonadotropin surge followed by receptor downregulation. Similarly, native Gonadorelin is employed to measure immediate pituitary responsiveness without the prolonged half-life associated with synthetic analogs. Researchers analyzing broader physiological control mechanisms may also compare these neuropeptide pathways against systemic growth axis modifiers like CJC-1295 or BPC-157 within multi-system endocrine screening models. Detailed technical literature on these pathways can be explored in our peptide research library.

8. Storage Protocols and Handling Requirements

To preserve the chemical stability of lyophilized Kisspeptin-10 20mg vials, intact units must be stored in a dry, dark environment maintained between -20°C and -80°C upon receipt. Under these conditions, the unhandled lyophilized cake remains stable for up to 24 months. Vials shipped from our USA facilities (located in California and Arizona) are sealed under inert nitrogen atmosphere to prevent oxidative degradation and moisture absorption during transit.

Prior to reconstitution, the sealed glass vial should be allowed to acclimate to room temperature. Introducing cold diluent directly into a freeze-dried cake at sub-zero temperatures can induce thermal shock or incomplete dissolution. Reconstitution diluent should be gently introduced along the inner glass wall of the vial, allowing the solvent to slowly saturate the lyophilized powder. The vial should be gently swirled; violent agitation or vortexing must be strictly avoided to prevent mechanical denaturing of the peptide structure.

9. Determining the Ideal Vial Size for Laboratory Workflows

Selecting between a standard 10mg unit and a 20mg high-mass vial depends on experimental scale, reconstituting frequency, and overall storage capacity. For exploratory pilot studies, single-plate in vitro receptor assays, or short-term rodent cohort trials, smaller vial configurations are often optimal. They allow laboratories to reconstitute only the necessary mass, minimizing the risk of extended liquid-state storage degradation.

Conversely, large-scale comparative bioassays, multi-center studies, or high-throughput automated screening setups benefit significantly from a 20mg vial spec. Utilizing a larger mass fill ensures identical batch characteristics across hundreds of micro-plate wells, reduces inter-assay variability, and streamlines reconstitution handling protocols. When choosing a vial size, research teams should balance their daily mass requirements against the maximum stable shelf-life of reconstituted aliquots.